These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31577512)

  • 21. Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study.
    Millard D; Dang Q; Shi H; Zhang X; Strock C; Kraushaar U; Zeng H; Levesque P; Lu HR; Guillon JM; Wu JC; Li Y; Luerman G; Anson B; Guo L; Clements M; Abassi YA; Ross J; Pierson J; Gintant G
    Toxicol Sci; 2018 Aug; 164(2):550-562. PubMed ID: 29718449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Properties of Engineered Heart Slices Incorporating Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Blazeski A; Lowenthal J; Zhu R; Ewoldt J; Boheler KR; Tung L
    Stem Cell Reports; 2019 May; 12(5):982-995. PubMed ID: 31056480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
    Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
    Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of high glucose and insulin on the electrophysiological properties of cardiomyocytes derived from human-induced pluripotent stem cells.
    Wei F; Zhang Y; Wang X; Huo J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):610-618. PubMed ID: 35753731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contractility assessment using aligned human iPSC-derived cardiomyocytes.
    Satsuka A; Ribeiro AJS; Kawagishi H; Yanagida S; Hirata N; Yoshinaga T; Kurokawa J; Sugiyama A; Strauss DG; Kanda Y
    J Pharmacol Toxicol Methods; 2024; 128():107530. PubMed ID: 38917571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.
    Yechikov S; Copaciu R; Gluck JM; Deng W; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2016 Nov; 34(11):2670-2680. PubMed ID: 27434649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A detailed characterization of the hyperpolarization-activated "funny" current (I
    Giannetti F; Benzoni P; Campostrini G; Milanesi R; Bucchi A; Baruscotti M; Dell'Era P; Rossini A; Barbuti A
    Pflugers Arch; 2021 Jul; 473(7):1009-1021. PubMed ID: 33934225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
    El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
    Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes.
    Caspi O; Itzhaki I; Kehat I; Gepstein A; Arbel G; Huber I; Satin J; Gepstein L
    Stem Cells Dev; 2009; 18(1):161-72. PubMed ID: 18510453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology.
    Hayakawa T; Kunihiro T; Ando T; Kobayashi S; Matsui E; Yada H; Kanda Y; Kurokawa J; Furukawa T
    J Mol Cell Cardiol; 2014 Dec; 77():178-91. PubMed ID: 25257913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility.
    Pfannkuche K; Liang H; Hannes T; Xi J; Fatima A; Nguemo F; Matzkies M; Wernig M; Jaenisch R; Pillekamp F; Halbach M; Schunkert H; Sarić T; Hescheler J; Reppel M
    Cell Physiol Biochem; 2009; 24(1-2):73-86. PubMed ID: 19590195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of gentamicin and penicillin/streptomycin on the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes in manual patch clamp and multi-electrode array system.
    Hyun SW; Kim BR; Lin D; Hyun SA; Yoon SS; Seo JW
    J Pharmacol Toxicol Methods; 2018; 91():1-6. PubMed ID: 29288713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes.
    Pölönen RP; Swan H; Aalto-Setälä K
    Mol Biol Rep; 2020 Feb; 47(2):1067-1077. PubMed ID: 31786768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
    Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico assessment of the effects of various compounds in MEA/hiPSC-CM assays: Modeling and numerical simulations.
    Abbate E; Boulakia M; Coudière Y; Gerbeau JF; Zitoun P; Zemzemi N
    J Pharmacol Toxicol Methods; 2018; 89():59-72. PubMed ID: 29066291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multielectrode Array Assays Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Yoshinaga D; Wuriyanghai Y; Makiyama T
    Methods Mol Biol; 2021; 2320():111-119. PubMed ID: 34302653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assay Procedures for Compound Testing of hiPSC-Derived Cardiomyocytes Using Multiwell Microelectrode Arrays.
    Kraushaar U; Guenther E
    Methods Mol Biol; 2019; 1994():197-208. PubMed ID: 31124117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells.
    Kikuchi C; Bienengraeber M; Canfield S; Koopmeiner A; Schäfer R; Bosnjak ZJ; Bai X
    Cell Transplant; 2015; 24(12):2491-504. PubMed ID: 25562386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The arrhythmogenic potential of nerve agents and a cardiac safety profile of antidotes - A proof-of-concept study using human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM).
    Amend N; Thiermann H; Worek F; Wille T
    Toxicol Lett; 2019 Jun; 308():1-6. PubMed ID: 30858091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.